Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AEB071 in Uveitis Patients with Macular Edema
NCT00615693Phase 2Completed
- Sponsor
- Novartis
- Start
- Jul 2008
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sotrastaurin in macular edema, intermediate uveitis (IU), posterior uveitis, panuveitis, sponsored by Novartis. Started Jul 2008; status: completed.
02
Drugs
sotrastaurin
03
Conditions
macular edemaintermediate uveitis (IU)posterior uveitispanuveitis
Beyond the preview
Go deeper on NCT00615693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00615693.